Does TENELIGLIPTIN Cause Off label use? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with TENELIGLIPTIN. This represents 4.7% of all adverse event reports for TENELIGLIPTIN.
8
Reports of Off label use with TENELIGLIPTIN
4.7%
of all TENELIGLIPTIN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From TENELIGLIPTIN?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENELIGLIPTIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TENELIGLIPTIN Cause?
Pemphigoid (29)
Hypoglycaemia (8)
Renal impairment (8)
Altered state of consciousness (7)
Diabetes mellitus inadequate control (7)
Diabetes mellitus (6)
Interstitial lung disease (6)
Cerebral infarction (5)
Drug eruption (5)
Glycosylated haemoglobin increased (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TENELIGLIPTIN Alternatives Have Lower Off label use Risk?
TENELIGLIPTIN vs TENIPOSIDE
TENELIGLIPTIN vs TENOFOVIR
TENELIGLIPTIN vs TENOFOVIR ALAFENAMIDE
TENELIGLIPTIN vs TENOFOVIR DISOPROXIL
TENELIGLIPTIN vs TEPLIZUMAB-MZWV